This approach recognises that insulin-induced mitochondrial, metabolic and endocrine dysregulation can occur below standard thresholds and provides a more sensitive and specific means of identifying early metabolic disease (16, 38, 40, 43, 56). This evidence concerns the gene INS and Other metabolic disease.